Loading...

Cognetivity Neurosciences Ltd.

CGNSF•PNK
Healthcare
Medical - Healthcare Information Services
$0.00
$0.00(0.00%)

Cognetivity Neurosciences Ltd. (CGNSF) Stock Overview

Explore Cognetivity Neurosciences Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 61.7/100

Key Financials

Market Cap9K
P/E Ratio-0.00
EPS (TTM)$-0.06
ROE0.96%
Fundamental Analysis

AI Price Forecasts

1 Week$0.00
1 Month$0.00
3 Months$0.00
1 Year Target$0.01

CGNSF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cognetivity Neurosciences Ltd. (CGNSF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.15, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.01.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.00 and a market capitalization of 9K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-80.00%
3-Month Change
5.26%
6-Month Change
-68.75%
Year-to-Date (YTD) Change
-33.33%
1-Year Change
-90.11%
3-Year Change
-99.29%
5-Year Change
-98.07%
All-Time (Max) Change
-99.43%

Contact Information

https://www.cognetivity.com
1055 West Hastings Street, Vancouver, BC, V6E 2E9

Company Facts

2,500 Employees
IPO DateJan 8, 2021
CountryCA
Actively Trading

Frequently Asked Questions

;